Glycosan Company
BioTime is leading the next revolution in medicine – regenerative medicine. Regenerative medicine utilizes advances in stem cell biology, biomaterials, lab-generated cells and tissues, and biologics to engineer and provide healthy cells, tissues and organs to patients with chronic degenerative diseases. This revolution in medical science changes the focus from treating the symptoms of chronic and degenerative diseases to providing actual cures.
Technology:
Stem Cell
Industry:
Regenerative Medicine
Headquarters:
United States
Founded Date:
2006
Employees Number:
501-1000
Funding Status:
M&A
Total Funding:
$950K
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership